Background/Aims Non-alcoholic fatty liver disease (NAFLD) is widespread chronic disease
of the live in humans with the prevalence of 30% of the United States population. 1, 2 The …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
throughout the world. Hepatocellular carcinoma (HCC) and liver cirrhosis can result from …

Objectives Steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis/cirrhosis represent a
spectrum of fatty liver disease. The ultrasound fatty liver indicator (US‐FLI) evaluates …

In the latter years in hepatology, due to new, very potent antiviral drugs that can eradicate or
control viral replication in chronic hepatitis C and B patients, witnessed a change in focus …

Hepatic steatosis without specific causes (eg, viral infection, alcohol abuse, etc.) is called
non-alcoholic fatty liver disease (NAFLD), which ranges from non-alcoholic fatty liver (NAFL) …

Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and... : Ultrasound Quarterly
Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing …

Non-alcoholic fatty liver disease (NAFLD) is extremely prevalent in the Western world. Non-
invasive diagnostic methods should be able to reflect the presence and severity of liver fatty …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common cause of liver test
abnormality and chronic liver disease in the world and can increase liver related mortality …

The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) has increased rapidly worldwide, along with increases in the prevalence of obesity …

Fatty liver is a very frequent disease in the modern world, due to the high prevalence of
obesity, type 2 diabetes, and metabolic syndrome. Known for long time as NAFLD …